Bull Horn shareholders approve Coeptis merger; 88.5% of public shares redeemed, trust drops to $3.8M

Z Squared Inc.

Shareholders approved all proposals: domestication to Delaware, merger with Coeptis, equity plan, charter amendments, and director election.
2,869,654 public shares (88.5% of outstanding) redeemed, leaving approximately $3.8 million in trust from the SPAC.
Post-merger company to be named Coeptis Therapeutics Holdings, Inc.; new board of seven directors elected.
Merger expected to close promptly after satisfaction of remaining conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.